The effect of upper airway surgery on obstructive sleep apnoea

Not Applicable

Recruiting

• Conditions: Obstructive sleep apnoea; Upper airway surgery; Respiratory - Sleep apnoea

• Registration Number: ACTRN12616001514493
• Lead Sponsor: Monash Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-11-03
• Last Update Posted: 7 December 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Confirmed diagnosis of obstructive sleep apnoea with an apnoea/hypopnoea index of greater than or equal to 15 events/hr. Diagnosis must be on level 1 or 2 sleep study and have occurred within at least 6 months enrolment into the trial.
Patients deemed appropriate and likely to respond to anatomically directed upper airway surgery as determined by staff specialists of the The Ear, Nose and Throat/Head and Neck Surgery Unit, Monash Health.

Exclusion Criteria

Significant co-morbid medical issues that would preclude surgery.
Administration of medications/drugs that interfere with ventilatory control.
Previous upper airway surgery for obstructive sleep apnoea. Patients cannot have any metallic implants/prostheses that would preclude magnetic resonance imaging (MRI) scanning.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Apnoea/hypopnoea index<br>Assessed by in laboratory polysomnography.[3 to 6 months following surgery]